Abstract
Bone and Soft Tissue Sarcomas (with Comments on Retroperitoneum and Adrenal Gland): this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM7 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the commoner non-carcinoma malignancies that are encountered at this site in diagnostic practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Allen DC. Histopathology reporting: guidelines for surgical cancer. 2nd ed. London: Springer; 2006.
Al-Nafussi A. Practical morphological approach to the diagnosis and differential diagnosis of soft tissue sarcomas. Curr Diagn Pathol. 2002;8:395–411.
Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathology. 2006;48:13–21.
Athanasou NA. Colour atlas of bone, joint and soft tissue pathology. Oxford: Oxford University Press; 1999.
Brenn T, Fletcher CDM. Postradiation vascular proliferations: an increasing problem. Histopathology. 2006;48:106–14.
Bullough PG. Orthopaedic pathology. 5th ed. St Louis: Mosby Elsevier; 2010.
Coffin CM, Lowichik A, Zhou H. Treatment effects in paediatric soft tissue and bone tumors. Am J Clin Pathol. 2005;123:75–90.
Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984;53:530–41.
Coindre J-M, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, de Mascarel I, de Mascarel A, Goussot JF. Reproducibility of a histopathogic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306–9.
Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2003;43:1–16.
Dei Tos AP. Classification of pleomorphic sarcomas: where are we now? Histopathology. 2006;48:51–62.
Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology. 2006;48:42–50.
Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby Wolfe; 1998.
Fechner RE, Mills SE. Tumors of the bones and joints. 3rd series. Fascicle 8. Washington, DC: AFIP; 1993.
Fisher C. The comparative roles of electron microscopy and immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2006;48:32–41.
Fisher C. Immunohistochemistry in diagnosis of soft tissue tumours. Histopathology. 2011;58:1001–12.
Fisher C, Montgomery E. Biopsy interpretation of soft tissue tumours. Philadelphia: Lippincott, Williams and Wilkins; 2010.
Fletcher CDM. The evolving classification of soft tissue tumour: an update based on the new WHO classification. Histopathology. 2006;48:3–12.
Fletcher CDM, Unni K, Mertens F. WHO classification of tumours. Pathology and genetics. Tumours of soft tissue and bone. Lyon: IARC Press; 2002.
Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61:428–37.
Guillou L. Pleomorphic sarcomas: subclassification, myogenic differentiation and prognosis. Diagn Histopathol. 2008;14:527–37.
Hahn HP, Fletcher CDM. The role of cytogenetics and molecular genetics in soft tissue tumour diagnosis – a realistic approach. Curr Diagn Pathol. 2005;11:361–70.
Holloway P, Kay E, Leader M. Myxoid tumours: a guide to the morphological and immunohistochemical assessment of soft tissue myxoid lesions encountered in general surgical pathology. Curr Diagn Pathol. 2005;11:411–25.
Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology. 2006;48:75–82.
Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK. Tumors of the soft tissues. 3rd series: Fascicle 30. Washington: AFIP; 2001.
McCarthy EF, Frassica FJ. Pathology of bone and joint disorders. Philadelphia: Saunders; 1998.
Miettinen MM. Diagnostic soft tissue pathology. New York: Churchill Livingstone; 2003.
Miettinen M, Fetsch JF. Evaluation of biological potential of smooth muscle tumours. Histopathology. 2006;48:97–105.
Mirra JM, Picci P, Gold RH. Bone tumours: clinical, radiological and pathological correlations. Baltimore: Lea and Febiger; 1989.
Nascimento AF. Rhabdomyosarcomas in adults: classification and differential diagnosis. Diagn Histopathol. 2008;14:538–45.
Pfeifer JD, Hill DA, O’Sullivan MJ, Dehner LP. Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology. 2000;37:485–500.
Pringle JAS. Osteosarcoma: the experiences of a specialist unit. Curr Diagn Pathol. 1996;3:127–36.
Rossi S, Laurino L, Dei Tos AP. Desmoid-type fibromatosis: from morphology to molecular genetics. Diagn Histopathol. 2008;14:546–51.
Rossi S, Nascimento AG, Canal F, Dei Tos AP. Small round-cell neoplasms of soft tissues: an integrated diagnostic approach. Curr Diagn Pathol. 2007;13:150–63.
Sinha H, Peach AHS. Diagnosis and management of soft tissue sarcoma. BMJ. 2011a;342:157–62.
The Royal College of Pathologists. Cancer Datasets (Primary Bone Tumours, Soft Tissue Sarcomas) and Tissue Pathways (Bone and Soft Tissue Pathology). Accessed at http://www.rcpath.org/index.asp?PageID=254.
Unni KK, Inwards CY. Dahlin’s bone tumors. 6th ed. Philadelphia: Lippincott, Williams and Wilkins; 2010.
Unni KK, Inwards CY, Bridge JA, Kindblom LG, Wold LE. Tumors of the bones and joints. AFIP atlas of tumor pathology. Series 4. Fascicle 8. Washington: AFIP; 2004.
Weiss SW, Goldblum SR. Enzinger and Weiss’s soft tissue tumors. 5th ed. St Louis: Mosby; 2007.
West RB, van de Rijn M. The role of microarray technologies in the study of soft tissue tumours. Histopathology. 2006;48:22–31.
Retroperitoneum
Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, et al. Short-course adjuvant chemotherapy in high-risk stage I non-seminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol. 1996;14:1106–13.
Parkinson MC, Harland SJ, Harnden P, Sandison A. The role of the histopathologist in the management of testicular germ cell tumour in adults. Histopathology. 2001;38:183–94.
Rosai J. Chapter 26. Peritoneum, retroperitoneum and related structures. In: Rosai J, editor. Rosai and Ackerman’s surgical pathology. 10th ed. Edinburgh: Elsevier; 2011.
Sinha S, Peach AHS. Diagnosis and management of soft tissue sarcoma. BMJ. 2011b;342:157–62.
Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, et al. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer. 1998;83:1409–19.
Adrenal Gland
DeLellis RA, Lloyd RV, Heitz PU, Eng C. WHO classification of tumours. Pathology and genetics. Tumours of endocrine organs. Lyon: IARC Press; 2004.
Hunt JL. Syndromes associated with abnormalities in the adrenal cortex. Diagn Histopathol. 2009;15:69–78.
Komminoth P, Perren A, van Nederveen FH, de Krijger RR. Familial endocrine tumours: phaeochromocytomas and extra-adrenal paragangliomas. Diagn Histopathol. 2009;15:61–8.
Lester SC. Chapter 11. Adrenal glands. In: Manual of surgical pathology. 3rd ed. Philadelphia: Elsevier/Saunders; 2010. p. 227–36.
McLean K, Lillenfeld H, Carracciolo JT, Hoffe S, Tourtelot JB, Carter WB. Management of isolated adrenal lesions in cancer patients. Cancer Control. 2011;18:113–25.
McNicol AM. Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma. Histopathology. 2011;58:155–68.
Singh PK, Buch HN. Adrenal incidentaloma: evaluation and management. J Clin Pathol. 2008;61:1168–73.
Stephenson TJ. Prognostic and predictive factors in endocrine tumours. Histopathology. 2006;48:629–43.
The Royal College of Pathologists. Cancer Datasets (Adrenal Cortical Carcinoma and Malignant Phaeochromocytoma/paraganglioma, Peripheral Neuroblastic Tumours) and Tissue Pathways for Endocrine Pathology. Accessed at http://www.rcpath.org/index.asp?PageID=254.
Volante M, Bollito E, Sperone P, Tavaglione V, Daffara F, Porpiglia F, Terzolo M, Berruti A, Pappoti M. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. Histopathology. 2009;55:535–43.
Volante M, Buttigliero C, Greco E, Berruti A, Pappoti M. Pathological and molecular features of adrenocortical carcinoma: an update. J Clin Pathol. 2008;61:787–93.
Westra WH, Hruban RH, Phelps TH, Isacson C. Chapter 38. Adrenal glands. In: Surgical pathology dissection: an illustrated guide. 2nd ed. New York: Springer; 2003.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Allen, D.C. (2013). Bone and Soft Tissue Sarcomas (with Comments on Retroperitoneum and Adrenal Gland). In: Histopathology Reporting. Springer, London. https://doi.org/10.1007/978-1-4471-5263-7_36
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5263-7_36
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5262-0
Online ISBN: 978-1-4471-5263-7
eBook Packages: MedicineMedicine (R0)